GNLX

Genelux Corp

• TipRanks·03/21 16:05

  Buy Rating Backed by Pivotal Olvi-Vec Ovarian Cancer Trial Progress and Multi-Indication Upside Potential

• Dow Jones·03/20 15:55

  Genelux Price Target Cut to $20.00/Share From $23.00 by Benchmark

• Dow Jones·03/20 15:55

  Genelux Is Maintained at Speculative Buy by Benchmark

• Benzinga·03/20 15:45

  Benchmark Maintains Speculative Buy on Genelux, Lowers Price Target to $20

• TipRanks·03/20 12:36

  Genelux price target lowered to $20 from $23 at Benchmark

• Reuters·03/20 11:09

  GENELUX CORP <GNLX.O>: BENCHMARK CUTS TARGET PRICE TO $20 FROM $23

• TipRanks·03/20 10:15

  Genelux: Advancing Olvi-Vec Pivotal Program and Manufacturing Readiness Underpin Buy Rating and Long-Term Value Upside

• Reuters·03/20 06:50

  U.S. RESEARCH ROUNDUP-Air Products, Chevron, FedEx

• TipRanks·03/19 21:17

  Genelux Establishes $100 Million At-The-Market Equity Program

• Reuters·03/19 20:57

  GENELUX CORP - ENTERS SALES AGREEMENT TO OFFER COMMON STOCK UP TO $100 MLN THROUGH TD COWEN- SEC FILING

• Benzinga·03/19 20:30

  Genelux Q4 EPS $(0.24) Misses $(0.21) Estimate

• Dow Jones·03/19 20:26

  *Genelux Sees Funding Sufficient Into 1Q27 >GNLX

• Dow Jones·03/19 20:26

  *Genelux 2025 Loss/Shr 86c >GNLX

• Dow Jones·03/19 20:25

  *Genelux 2025 Rev $8,000 >GNLX

• Reuters·03/19 20:15

  GENELUX CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES